bunalict 8+2 mg resoribletter, sublinguale
sandoz a/s - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg
buprenorphin "2care4" 200 mikrogram resoribletter, sublinguale
2care4 aps - buprenorphinhydrochlorid - resoribletter, sublinguale - 200 mikrogram
norvipren 200 mikrogram resoribletter, sublinguale
sandoz a/s - buprenorphinhydrochlorid - resoribletter, sublinguale - 200 mikrogram
temgesic 0,4 mg resoribletter, sublinguale
orifarm a/s - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,4 mg
buprenorphin/naloxon "g.l. pharma" 2+0,5 mg resoribletter, sublinguale
g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg
buprenorphin/naloxon "g.l. pharma" 8+2 mg resoribletter, sublinguale
g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg
buprenorphin/naloxon "mylan" 2+0,5 mg resoribletter, sublinguale
mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg
buprenorphin/naloxon "mylan" 8+2 mg resoribletter, sublinguale
mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg
sixmo
l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - buprenorphin hydrochlorid - opioid-relaterede lidelser - andre narkotika stoffer - sixmo er angivet til substitutionsbehandling for opioidafhængighed i klinisk stabile voksne patienter, der kræver mere end 8 mg/dag af sublingual buprenorphin, inden for en ramme af medicinsk, social og psykologisk behandling.
moventig
kyowa kirin holdings b.v. - naloxegol oxalat - constipation; opioid-related disorders - perifere opioid-receptor-antagonister, medicin mod forstoppelse - behandling af opioidinduceret forstoppelse (oic) hos voksne patienter, som har haft utilstrækkelig respons på afføringsmiddel (er).